EMEA-000700-PIP02-10
Key facts
| Invented name |
Galvus
|
| Active substance |
vildagliptin
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/177/2011
|
| PIP number |
EMEA-000700-PIP02-10
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Limited
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|